MedPath

Study on efficacy of Caucasian whortleberry in treatment of type 2 diabetic patients

Phase 3
Conditions
Type 2 diabetes mellitus.
Non-insulin-dependent diabetes mellitus type 2
Registration Number
IRCT138902292288N3
Lead Sponsor
Research Institute for Islamic and Complementary Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

type 2 diabetic patients, patients aged 40 to 60 years, patients with fasting glucose serum levels between 200 and 250 mg/dl, patients with glycosylated hemoglobin blood levels between 6.5 to 8 percent, patients whose blood glucose levels are not within the normal range despite using a combination of oral synthetic antidiabetic drugs. Exclusion criteria: patients with cardiac, renal or hepatic diseases, concomitant infections, pregnant women, women planning pregnancy, breast-feeding women.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fasting glucose serum level. Timepoint: 2 months. Method of measurement: Medical laboratory (kit).;Glycosylated hemoglobin blood level. Timepoint: 2 months. Method of measurement: Medical laboratory (kit).
Secondary Outcome Measures
NameTimeMethod
2 hours postprandial glucose serum level. Timepoint: 2 months. Method of measurement: Medical laboratory (kit).
© Copyright 2025. All Rights Reserved by MedPath